“我们正在中国香港进行IPO路演,但这段时间药企扎堆申报港股IPO,已形成了‘堰塞湖’,基石投资者和锚定投资者都快看不过来了,我们遭遇路演排队。”有赴港IPO药企人士对第一财经记者透露。 今年以来,港股医药二级市场的复苏,提振了企业们IPO融资热情。根据Choice金融终端数据,截至11月14日,港股的医疗保健板块今年累计迎来了23家企业成功上市,而去年同期仅有8家企业上市。 当前,还有不少...
Source Link“我们正在中国香港进行IPO路演,但这段时间药企扎堆申报港股IPO,已形成了‘堰塞湖’,基石投资者和锚定投资者都快看不过来了,我们遭遇路演排队。”有赴港IPO药企人士对第一财经记者透露。 今年以来,港股医药二级市场的复苏,提振了企业们IPO融资热情。根据Choice金融终端数据,截至11月14日,港股的医疗保健板块今年累计迎来了23家企业成功上市,而去年同期仅有8家企业上市。 当前,还有不少...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.